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The Kinetics and Mechanism of the Organo-Iridium- 
Catalysed Enantioselective Reduction of Imines 
Mathew J. Stirling*a, Gemma Sweeneya, Kerry MacRorya, A. John Blackerb and Michael I. Pagea   
The iridium complex of pentamethylcyclopentadiene and (S,S)-1,2-diphenyl-N′-tosylethane-
1,2-diamine is an effective catalyst for the asymmetric transfer hydrogenation of imine 
substrates under acidic conditions. Using the Ir catalyst and a 5:2 ratio of formic acid: 
triethylamine as the hydride source for the asymmetric transfer hydrogenation of 1-methyl-3,4-
dihydroisoquinoline and its 6,7-dimethoxy substituted derivative, in either acetonitrile or 
dichloromethane, shows unusual enantiomeric excess (ee) profiles for the product amines. The 
reactions initially give predominantly the (R) enantiomer of the chiral amine products with 
>90% ee but which then decreases significantly during the reaction. The decrease in ee is not 
due to racemisation of the product amine, but because the rate of formation of the (R)-
enantiomer follows first-order kinetics whereas that for the (S)-enantiomer is zero-order. This 
difference in reaction order explains the change in selectivity as the reaction proceeds - the rate 
formation of the (R)-enantiomer decreases exponentially with time while that for the (S)-
enantiomer remains constant. A reaction scheme is proposed which requires rate-limiting 
hydride transfer from the iridium hydride to the iminium ion for the first-order rate of 
formation of the (R)-enantiomer amine and rate-limiting dissociation of the product for the 
zero-order rate of formation of the (S)-enantiomer. 
 
 
 
Introduction 
Chiral amines make up a significant fraction of the current portfolio 
of pharmaceuticals and agrochemicals1. Therefore there has been an 
extensive search for an enantioselective synthesis of these important 
constituents suitable for their large-scale manufacture. Due to 
economic and environmental pressures these processes need to be 
achieved with the minimum number of chemical steps, be energy 
and atom efficient, not produce toxic waste and, ideally, involve 
catalytic methods. Catalytic transfer hydrogenation (TH) is an 
attractive alternative to the direct reduction of substrates, avoiding 
the need for molecular hydrogen.2,3,4 The first homogeneous 
catalytic systems appeared in the late 1960s and were based on 
iridium compounds5,6  which were followed by the introduction of 
the versatile pentamethylcyclopentadienyl anion iridium and 
rhodium (Cp*Ir and Cp*Rh) catalyst precursors for these 
transformations7,8, 9,10  and their variants.11,12,13  
Although the highly selective asymmetric reduction of alkenes and 
ketones has been accomplished using chiral rhodium and ruthenium 
catalysts,14 the hydrogenation of imines using similar catalysts has 
proved much less successful.15 Furthermore, most 
enantioselectivities obtained are moderate and require a high catalyst 
loading. Asymmetric transfer hydrogenation (ATH) commonly uses 
propan-2-ol or formic acid as the hydrogen donor, in conjunction 
with a chiral organometallic catalyst such as Noyori’s ruthenium 
based complex16 (1) and the iso-electronic rhodium (2) and iridium 
(3) CATHy catalysts17. 
Page 1 of 11 Organic & Biomolecular Chemistry
O
rg
an
ic
&
B
io
m
ol
ec
ul
ar
C
he
m
is
tr
y
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
10
 M
ar
ch
 2
01
6.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f H
ud
de
rs
fie
ld
 o
n 
15
/0
3/
20
16
 1
1:
06
:3
5.
 
View Article Online
DOI: 10.1039/C6OB00245E
ARTICLE Journal Name 
2 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 2012 
 
There are two mechanisms18 commonly suggested for these metal-
catalyzed transfer hydrogenation reactions: either a metal hydride is 
involved in the hydrogen transfer step (4) and (5) or the metal 
facilitates hydride transfer between the hydride donor and the 
substrate as in a Meerwein–Ponndorf–Verley type reduction (6). The 
most favoured pathways are those involving the metal-hydride which 
may occur by inner-sphere (4),18 where the substrate is coordinated 
to the metal prior to hydride transfer, or outer-sphere (5) 
processes,19,20,21 both of which assume full retention of all ancillary 
ligands. The inner sphere mechanism generates an alkoxide anion 
bound to the metal which requires protonation to release the product 
alcohol and hydride transfer to the metal to regenerate the catalyst. 
The commonly accepted mechanism for the Cp*Ir-catalyzed 
asymmetric transfer hydrogenation of ketones is that involving a 
concerted process with the transfer of a metal hydride and a ligand 
proton occurring through a six-membered cyclic transition state i.e. 
outside the direct coordination sphere of the metal (5).22,23 In the 
outer-sphere mechanism the metal-bound ligand, shown as NH in 
(5), is important in contributing to both proton and hydride transfer 
through its acidity. Relatively, if it is a better proton donor it will 
activate the carbonyl carbon towards nucleophilic attack but as a 
weaker Lewis base it will increase the positive charge density on the 
metal retarding hydride transfer. In some processes the proton 
transfer step to the carbonyl oxygen is facilitated by an external 
acid.18 The picture presented in the inner sphere mechanism (4) 
formally requires an expansion of the coordinatively and 
electronically saturated metal and it has been suggested that prior 
ligand dissociation must occur24 although some pathways are 
thought to involve the cooperative participation of two metal 
centres.25 A recent study of a Cp*Ir complex provided evidence for 
displacement of the Cp* ligand which may be relevant to hydrogen 
transfer catalysis by providing the assumed required vacant 
coordination site.26 
 
The transfer hydrogenation of imines to amines and the 
corresponding reverse reaction are expected to show significant 
differences to the ketone/alcohol reaction because of the differences 
in basicity, susceptibility to nucleophilic attack and their ability to 
bind to metal ions. There have been fewer investigations into the 
imine/amine reaction using organometallic catalysts, although 
kinetic and isotope labelling studies using a cyclopentadienone 
ruthenium catalyst27,28 have attempted to differentiate an inner 
sphere mechanism, involving direct coordination of the substrate to 
the metal, and an outer sphere process in which the amine/imine 
nitrogen does not bind directly to the ruthenium. Distinguishing 
between stepwise and concerted hydride and proton transfer steps is 
also controversial29. It has been suggested30 that the asymmetric 
transfer hydrogenation of imines with formic acid-triethylamine 
mixtures using Rh-chiral diamine catalysts involves the neutral 
imine as the reactive species, whereas prior imine protonation has 
been proposed because the isolated ruthenium hydride reacts faster 
with an imine substrate than a corresponding ketone due to the 
greater basicity of the imine.31,32,33 Based on studies of the 
nucleophilic addition to imines in aqueous solution, it may be 
expected that the iminium would be the reactive species,34 however 
recent iridium transfer hydrogenation catalysts have been developed 
by Crabtree35 which are highly active under neutral and basic 
conditions. Finally, the concerted metal-ligand bifunctional 
mechanism 22,23 is presumably required when the neutral imine is the 
reactive species to prevent formation of the unstable nitrogen anion 
(7), but if the iminium species is involved then the necessity for 
protonation from a bound ligand is less likely and with no available 
nitrogen lone-pair proton transfer would have to occur through the π-
bond (8).  
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The origin of enantioselection is also unclear with respect to the 
transfer hydrogenation of imines using Noyori / CATHy catalysts.  
Computational calculations36 indicate that the control of 
stereochemistry in the transfer hydrogenation of aromatic ketones is 
due to a favourable π/CH interaction between a hydrogen atom on 
the η6-arene ligand and the aromatic ring of the substrate (9). 
However, the transfer hydrogenation of aromatic imines leads to 
chiral amines with the opposite stereochemistry from that expected 
applying a similar rational. Based on the effect of N-alkylation of the 
diamine ligand in the Ru complex (1) an ionic outer sphere 
mechanism for the asymmetric transfer hydrogenation of imines was 
proposed involving hydride transfer to the iminium ion whilst 
maintaining the π/CH interaction37 (9). 
 
A detailed understanding of the mechanism of imine transfer 
hydrogenation would facilitate the design of more active and 
selective catalysts as well as optimisation of the process conditions 
minimising catalyst loading and deactivation. Herein we investigate 
the mechanism of the asymmetric transfer hydrogenation of imines 
using iridium CATHy catalysts (3).8 
 
Results and Discussion 
The iridium based CATHy catalyst (3) is an effective catalyst for the 
transfer hydrogenation of imine substrates under acidic 
conditions.8,17 It is usually formed in-situ through the reaction of the 
pentamethylcyclopentadienyl metal dimer (IrCp*Cl2)2 (10, X = Cl) 
and the ligand (S,S)-1,2-diphenyl-N′-tosylethane-1,2-diamine 
(TsDPEN). The synthesis of chiral 1,2,3,4-tetrahydroisoquinoline 
(13) derivatives is of interest because they often exhibit bioactivity 
with a potential use as drugs.38 Using the Ir catalyst (3) for the 
asymmetric transfer hydrogenation of 1-methyl-3,4-
dihydroisoquinoline (11) and its 6,7-dimethoxy substituted 
derivative (12), in either acetonitrile or dichloromethane, there are 
unusual enantiomeric excess (ee) profiles for the product amines 
(13) and (14), respectively. The reactions are carried out using a 
mixture of triethylamine and formic acid with the latter in excess in a 
ratio of 2:5. Under these conditions the reactant imine, triethylamine 
and the product amine are 100% protonated as shown by NMR 
studies (see ESI). The pKa of formic acid in acetonitrile, which has 
not been reported, can be estimated to be 20.9 from the very good 
relationship of the acidities of other carboxylic acids between 
acetonitrile and water39. The pKa of the conjugate acid of 
triethylamine in acetonitrile is 18.5, so at low concentrations the 
equilibrium constant for the acid-base equilibrium (eq.1) is expected 
to be 4 x 10-3. However, the overall equilibrium constant K is 
influenced by ion-pairing in solvents of low dielectric constant so 
that K = Ke x Kip (eq.1) and as  ion-pairing constants are typically of 
the order 102-103 M-1 40 and with the high concentrations of formic 
acid (2.4M), triethylamine (0.96M) and imine (0.4M) typically used, 
it is not surprising that under the experimental conditions used both 
bases are fully protonated. Furthermore, the solvent system is not 
just acetonitrile; it is a mixture of acetonitrile, ca. 10% formic acid 
and ca. 10% triethylamine so the solvent polarity is much higher 
than pure acetonitrile and the pKa of formic acid will be lower than 
the value in pure acetonitrile. The reduction consumes one 
equivalent of formic acid but there is still an excess of formic acid at 
the end of the reaction.  
 
The reactions initially give predominantly the R enantiomer of the 
chiral amines (13) and (14) with > 90% ee which then decreases 
significantly during the reaction. For example, using the standard 
reaction conditions of 0.4 M imine (11), 0.5 mol% of catalyst (3), 6 
equivalents of formic acid (2.4 M) triethylamine (0.96 M) (5:2 ratio 
formic acid : triethylamine, TEAF)  at 20 0C in either acetonitrile or 
dichloromethane the ee drops from about 80% and 60% to 20% or 
zero, respectively (Figs. 1 and 2).  
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Fig.1 Change in concentration M (■) of product amine (14) during the 
transfer hydrogenation of 0.40M imine (12) in acetonitrile with catalyst 
((S,S)-3) and the change in % enantiomeric excess (ee) () of product amine 
(14) as a function of time. 
The enantioselectivity of the transfer hydrogenation is solvent 
dependent, with faster rates being favoured by dichloromethane but 
greater enantioselectivity in acetonitrile. In both solvents the 
enantiomeric excess decreases with increasing conversion, 
remaining constant after the reduction has reached completion. A 
possible explanation is that the product amine is racemised under the 
reaction conditions41. However, the enantiomeric excess of the 
amine formed during the transfer hydrogenation remains constant 
after the reduction is complete.  Furthermore, under the standard 
reaction conditions containing the (R) amine (14) in dichloromethane 
with  
Fig. 2 Change in concentration M (■) of product amine (14) during the 
transfer hydrogenation of 0.40M imine (12) in dichloromethane with catalyst 
((S,S)-3) and the change in % enantiomeric excess (ee) () of product amine 
(14) as a function of time. 
 
the catalyst (3) and 5:2 formic acid / triethylamine there is no 
racemisation after 12 hours. This lack of racemisation is not 
surprising as formate is a better hydride donor than the amine and 
the acidic nature of the medium means the amine is in its protonated 
form and unlikely to readily bind to the iridium catalyst. In 
dichloromethane the ee decreases to below zero, suggesting 
increased selectivity for the other enantiomer of the product amines 
(13) and (14) as the reaction progresses, rather than racemisation 
causing the decrease in ee. Finally, the large excess of formic acid 
and absence of a hydrogen acceptor indicates that the resting state of 
the catalyst is likely to be the 18-electron iridium hydride, (3), rather 
than the 16-electron species, (15), required for dehydrogenation.  
The enantiomeric excess decreases at similar rates for various ratios 
of catalyst (3) to imine from 0.1 to 1.0 mol%. Analysis of the overall 
reaction profiles revealed that they do not obey first-order kinetics 
and appear to lie somewhere between zero and first-order. This is a 
consequence of the rate of formation of the (R)-enantiomer 
following first-order kinetics whereas that for the (S)-enantiomer is 
zero-order (Fig 3). This difference in reaction order explains the 
change in selectivity as the reaction proceeds - the rate formation of 
the (R)-enantiomer decreases exponentially with time while that for 
the (S)-enantiomer remains constant. As the reaction progresses the 
reaction becomes increasingly selective for the (S)-enantiomer which 
constitutes an ever increasing fraction of the total rate of the 
conversion of imines (11) or (12) to chiral amines (13) or (14), 
respectively, to the point where the rate of formation of the (S)-
0
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enantiomer exceeds that of the (R)-enantiomer. For example, using 
0.25 mol% of the iridium catalyst (3) the concentration of the (S)-
enantiomer (14) exceeds that of the (R)-enantiomer after 30 mins 
(Fig.3). 
Using the (R,R)-, rather than the (S,S)-, ligand TsDPEN to generate 
the iridium catalyst (3) inverts the kinetic profiles so that the 
reduction of the imine (11) in dichloromethane produces the (R)-(13) 
by zero-order kinetics and the (S)-enantiomer by a first-order 
process.  
 
Fig. 3 Rate profiles for the formation of the (S)(O) - and (R)(+)- enantiomers 
of (14) for the transfer hydrogenation of 0.40M (12) using 0.25 mol% of the 
iridium catalyst (3) in dichloromethane at 20oC 
There are several possible explanations for the differences in the 
kinetic profiles for the formation of the two enantiomers using the 
(S,S)-TsDPEN ligand: 
(i) The formation of the (S)-enantiomer involves tight binding of the 
imine to a single catalytic species, or slow dissociation of the 
product (S) amine from the catalyst, giving rise to saturation and 
zero-order kinetics; whereas the (R)-enantiomer is produced 
from weaker catalyst binding so exhibiting below saturation, 
first-order, kinetics. 
(ii) There are different rate limiting steps for the formation of each 
enantiomer such that the formation of the (S)-enantiomer is 
independent of the concentration of the imine. 
(iii) There are two distinct species of the iridium catalyst each 
responsible for the separate formation of each enantiomer. The 
two catalytic processes have different rate limiting steps or 
equilibria such that the rate of formation of the (S)-enantiomer is 
independent of the concentration of imine. 
The zero-order rate of formation of the (S)-enantiomer changes 
proportionally with catalyst concentration (Fig.4) to give a first-
order rate constant of 5.12 x 10-2 s-1.  The rate of formation of the (R) 
enantiomer also shows a first-order dependence on the catalyst 
concentration giving an overall second order rate constant of 0.875 
M-1s-1. 
Fig. 4 Reaction profile for the formation of (S)-(14) at different catalyst 
loadings of the iridium catalyst (3) (0.50 mol% (■), 0.25 mol% (+) and 0.125 
mol% (o)) in the transfer hydrogenation of 0.4M (12) using 6 M equiv. TEAF 
in dichloromethane at 20oC. 
 
The catalytic rate constants for the transfer hydrogenation of imines 
(11) or (12) to chiral amines (13) or (14), respectively, catalysed by 
the iridium complex 3 in acetonitrile and dichloromethane are given 
in Table 1. The dimethoxy imine (12) is at least 10-fold more basic 
than the unsubstituted imine (11)32 and yet there is less than a two-
fold difference in reactivity for the formation of both enantiomers 
(Table 1). 
Table 1 The first and second order catalytic rate constants for the 
reduction of imines 11 and 12 catalysed by the iridium complex 3 in 
acetonitrile and dichloromethane (DCM) at 20oC. 
Rate 
constant 
Unsubstituted imine (11) Dimethoxy imine (12) 
acetonitrile DCM acetonitrile DCM 
k(S)/s-1 2.01 x 10-2 7.27 x 10-2 9.80 x 10-3 5.12 x 10-2 
k(R)/M-1s-1 0.595 1.40 0.481 0.875 
 
The enantioselectivity of the reaction system is dependent on the 
concentration of imine, being (R)-selective at high concentrations 
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and (S)-selective at low concentrations. Starting with the standard 
reaction conditions the transfer hydrogenation of (12) in 
dichloromethane was followed by a second aliquot addition of 0.4 M 
imine (12) and 2 M equivalents of formic acid after the reduction of 
the first aliquot had reached completion (Fig. 5). There is a change 
in the rate of decrease in enantioselectivity as the second aliquot of 
imine is added as expected if the reaction becomes more (R)-
selective on the addition of imine. The rate of formation of amine 
during the reduction of the second aliquot of amine is approximately 
half of that for the reduction of the first aliquot: the first-order rate of 
formation of the (R)-enantiomer is approximately halved during the 
reduction of the second aliquot whereas the zero-order rate of 
formation of the (S)-enantiomer is slightly decreased as expected  
Fig. 5 Formation of (R)- (+) and (S)- (o) enantiomers of amine (14) during 
the transfer hydrogenation of 0.40M (12) using 0.5 mol% of the iridium 
catalyst (3) and 6 equiv. TEAF in dichloromethane at 20oC with the addition 
of 0.40 M (12)  and 2 equiv. formic acid after 35 minutes. 
from the 10% dilution for the second phase. The major difference 
between the two reaction phases is the presence of 0.4 M product 
amine (14). 
It is possible that the amine product (14) acts as a ligand for the 
iridium species. However, adding 0.2 M (R)- or (S)-, or racemic (14) 
at the start of the reaction just prior to the addition of TEAF reduced 
the overall rate of reduction, the zero-order rate of formation of the 
(S)-enantiomer, and the exponential rate of formation of (R)-(14) by 
less than half. This small effect of added amine product could be just 
a general base effect rather than specific interaction with the iridium, 
so the transfer hydrogenation was repeated with the addition of 0.2 
M triethylamine to the standard conditions of 6 equivalents of formic 
acid (2.4 M) and triethylamine (0.96 M) which resulted in the 
similar, relatively small, changes seen with added amine product 
(14). Finally, the catalytic reduction was carried out with excess (0.4 
M) of the ligand (S,S)-1,2-diphenyl-N′-tosylethane-1,2-diamine 
(TsDPEN) with (5x10-4 M) iridium dimer [IrCp*Cl2]2 (10) which 
shows the usual profile of being more selective for the (R)-
enantiomer, and the decrease in the enantiomeric excess similar to 
that of the standard reaction (Fig. 6). The effect of additional ligand 
is similar to that of other added amines and indicates that there is no 
unreacted iridium dimer (3) present in the standard reaction 
conditions and that the catalytic species contains a single molecule 
of (S,S)-TsDPEN which does not dissociate during catalytic 
turnover. The enantiomeric excess is greater with excess ligand 
throughout the reaction and the overall profile is much closer to first-
order as the excess of ligand favours the formation of the (R)-
enantiomer compared with the standard conditions. The observed  
Fig. 6 The change in amine (14) concentration and % ee with 0.25mol% 
TsDPEN (x) and (o) respectively and with 100mol% TsDPEN (■) and (•) 
respectively for the reduction of 0.4M (12) using 1.0 mM of the iridium 
catalyst (3) and 6 equiv. TEAF in dichloromethane at 20oC with the addition 
of 1.0 mM and 0.4 M (S,S)-TsDPEN. 
zero-order rate of formation of (S)-(14) with excess ligand is nearly 
halved compared with 0.25 mol% (S,S)-TsDPEN, whereas the first-
order rate constant for the formation of (R)-12 is slightly greater than 
with a catalytic amount of ligand. There are two steps during 
catalytic reduction and turnover which require hydride transfer – 
reduction of the iridium species (15) by formate to regenerate the 
catalyst (3) and hydride transfer from the catalyst (3) to the iminium 
ion. The first-order rate of formation of the (R)-enantiomer shows a 
small but significant deuterium kinetic isotope effect (KIE) (kH/kD 
=1.55) using deuterated formic acid (DCO2H), whereas the zero-
order rate of formation of the (S)-enantiomer shows no KIE (kH/kD 
=1.00). 
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The interactions of the imine reactant and amine product with the 
iridium-ion and the rates of hydride transfer are expected to be  
dependent on the effective positive charge on the metal-ion. A 
simple way to modify this effective charge and hence change 
catalytic activity is with a substituent in the cyclopentadienyl residue 
such as the amide (16)42. The electron-withdrawing amide 
substituent in 16 presumably decreases the electron density in the 
cyclopentadiene anion ring, making the iridium-ion relatively more 
positive compared with that in the unsubstituted catalyst 3. Using the 
(S,S)- ligand TsDPEN, the ATH of the imine 12 with the substituted 
catalyst 16 in dichloromethane at 20oC is much slower than that with 
the unsubstituted Cp* (3). However, the rate of formation of the (R)-
product amine 14 still follows first-order kinetics whereas that for 
the (S)-enantiomer is zero-order as seen for the catalyst 3. Both 
catalytic constants for (R)- and (S)-enantiomer formation using 16 
are about 130-fold less than the analogous ones using catalyst 3 
(Table 1); k (R) being 6.46x10-3 M-1s-1 and k (S) = 4.17 X10-4 s-1. 
 
All of the above observations can be used to deduce a reaction 
mechanism. To generate both enantiomeric amine products from a 
single catalytic species requires hydride transfer to occur with 
different orientations of the iminium ion with respect to the catalyst 
(Scheme 1). It has been suggested that the orientation of the iminium 
ion to the catalyst is controlled by its H-bonding to either the metal-
bound -NH2
43 (even though there is no available electron pair) or the 
sulfonyl oxygens44 of the diamine ligand. Such a scheme requires 
rate-limiting hydride transfer from the iridium hydride to the 
iminium ion for the first-order rate of formation of the (R)-
enantiomer amine (k2 in Scheme 1) and rate-limiting dissociation of 
the product for the zero-order rate of formation of the (S)-enantiomer 
(k3 in Scheme 1). 
 
These different rate-limiting steps are compatible with the observed 
different kinetic orders and the KIE for formation of the two 
enantiomers.  The slower zero-order rate of catalytic ATH observed 
for formation of the S-enantiomer by the amide substituted iridium 
derivative (16) would also be explained by the slower rate of 
dissociation of the amine product (k3 in Scheme 1) due to the greater 
positive charge on the metal-ion. For the first-order formation of the 
R-amine, this additional positive charge density on the iridium 
would decrease the rate of hydride transfer (k2 in Scheme 1). 
If the ATH occurs with two catalytic species being present then the 
observations could be explained with two diastereomeric species of 
the iridium hydride each having different catalytic activities 
(Scheme 2). In this case the zero-order rate of formation of the (S)-
enantiomer is unlikely to occur with rate-limiting formation of the 
catalyst by hydride transfer from formate ion because of the lack of a 
KIE, but again could involve rate-limiting dissociation of the product 
(S)-amine. The first-order rate of formation of the (R)-enantiomer 
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amine could involve rate-limiting hydride transfer from the iridium 
hydride to the iminium ion. At present it is not possible to 
distinguish between these two schemes. 
 
 
Conclusions 
The iridium complex of pentamethylcyclopentadiene and (S,S)-
1,2-diphenyl-N′-tosylethane-1,2-diamine is an effective catalyst 
for the asymmetric transfer hydrogenation of imine substrates 
under acidic conditions. Using the Ir catalyst for the 
asymmetric transfer hydrogenation of 1-methyl-3,4-
dihydroisoquinoline and its 6,7-dimethoxy substituted 
derivative, in either acetonitrile or dichloromethane, shows 
unusual enantiomeric excess (ee) profiles for the product 
amines. The reactions initially give predominantly the (R) 
enantiomer of the chiral amine products with > 80% ee but 
which then decreases significantly during the reaction. The 
decrease in ee is not due to racemisation of the product amine, 
but because the rate of formation of the (R)-enantiomer follows 
first-order kinetics whereas that for the (S)-enantiomer is zero-
order. This difference in reaction order explains the change in 
selectivity as the reaction proceeds - the rate formation of the 
(R)-enantiomer decreases exponentially with time while that for 
the (S)-enantiomer remains constant.  
 
 
Experimental 
Reaction Procedures. Unless stated otherwise,  the reactions were 
followed using 0.4 M imine (12), x mol% 
pentamethylcyclopentadienyl metal dimer (IrCp*Cl2)2 (10, X = Cl); 
2x mol% of the ligand (R,R) or (S,S)-1,2-diphenyl-N′-tosylethane-
1,2-diamine (TsDPEN); 6 and 2.4 mole equivalents of formic acid 
and triethylamine, respectively (5:2 ratio formic acid : triethylamine, 
TEAF) in either acetonitrile or dichloromethane at 20oC. For 
example, pentamethylcyclopentadienyliridium (III)  chloride dimer, 
10 (X= Cl), (11.7 mg, 0.0147 mmol), (S,S)-TsDPEN (10.8 mg,  
0.0294 mmol) and 6,7-dimethoxy-1-methyl-3,4-dihydroisoquinoline, 
12, (1.204 g, 5.873 mmol) were dissolved in acetonitrile (11.7 ml) at 
20 oC. The reaction solution was agitated using a magnetic stirrer 
and sparged at 50 ml/min with acetonitrile saturated nitrogen, passed 
through this solvent prior to entering the reaction flask, for 30 mins. 
TEAF (3.048g, 35.24 mmol formic acid) was then added in one 
aliquot and the reaction then sampled at regular intervals for GC 
analysis by quenching ~200 µl into 2.5 M sodium hydroxide (2.0 ml) 
/ dichloromethane (2.0 ml), isolating and drying the organic layer 
using sodium sulfate. 
Analytical. The following methods were used for the analysis of all 
transfer hydrogenation reactions using 12 as the substrate: GC 
column - HP Crosslinked 5% Ph Me siloxane (25 m x 0.32 mm x 
0.52 µm); oven temp. 150 oC for 7 mins., then ramped at 10oC/min 
to 300oC and held for 5 mins.; inlet pressure 12.0 psi. 6,7-
Dimethoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline, 12, retention 
time 12.4 mins., 6,7-Dimethoxy-1-methyl-3,4-dihydroisoquinoline, 
14, retention time  12.7 mins. Capillary electrophoresis (for ee): 
Beckman Coulter P/ACE MDQ; bare fused silica capillary column 
(31 cm x 50 µm, effective length = 21 cm); voltage -15.0 kV; eluent 
pH 2.5 triethylammonium phosphate buffer containing 2.0% w/v 
highly sulfated γ-cyclodextrin; detector wavelength 200 nm. 12 
retention time 3.48 mins., retention times: (R)- 14 4.93 mins., (S)-14 
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7.13 mins. G. C. (for ee): samples were derivatised using 
trifluoroacetic anhydride prior to injection; Varian Chirasil -Dex-CB 
column (25 m, 250 µm, 0.25 µm); oven temp. 165oC isothermal for 
60 mins., inlet pressure 10.0 psi., retention times: (R)-14 = 41.6 
mins., (S)-14 = 42.5 mins. 
Attempted racemisation of (R)-6,7-dimethoxy-1-methyl-1,2,3,4-
tetrahydroisoquinoline. 12, Pentamethylcyclopentadienyliridium 
(III) chloride dimer, 10, (1.9 mg, 2.385 x 10-3 mmol) and (R)-6,7-
dimethoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline, 14, (100 mg, 
0.487 mmol) were dissolved in dichloromethane (1.95 ml) to give an 
orange solution that was agitated using a magnetic stirrer. Samples 
were taken after 2 and 12 h and analysed by GC by adding one drop 
to a GC vial containing dichloromethane by chiral capillary 
electrophoresis by adding 200 µl of the reaction solution to 10 ml 
ultra-pure water. A similar experiment was conducted in the 
presence of a solution of TEAF, in which 
pentamethylcyclopentadienyliridium (III) chloride dimer, 10, (1.9 
mg, 2.385 x 10-3 mmol), (S,S)-TsDPEN (1.8 mg, 4.9 x 10-3 mmol), 
(R)-6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline, 14, (100 
mg, 0.4873 mmol) and a pre-prepared TEAF solution in 
dichloromethane(1.95ml, 1.225 x 10-2 mmol HCO2H) resulting in an 
orange solution that was agitated using a magnetic stirrer. Samples 
were taken after 2 and 12 h and analysed as above. Finally, the 
experiments were repeated using (R)-6,7-dimethoxy-1-methyl-
1,2,3,4-tetrahydroisoquinoline, 14, Iridium CATHy catalyst, 3 and 6 
mol. eq. formic acid.  
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